Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer

Clinical Cancer Research

Volumn 17, Issue 9, 2011, Pages 2657-2667

  Oh, Hue Kian ^a   Tan, Angie Lay Keng ^a   Das, Kakoli ^a   Ooi, Chia Huey ^a   Deng, Nian Tao ^a   Tan, Iain BeeHuat ^a   Beillard, Emmanuel ^a   Lee, Julian ^a   Ramnarayanan, Kalpana ^a   Rha, Sun Young ^d   Palanisamy, Nallasivam ^b,e   Voorhoeve, P Mathijs ^a   Tan, Patrick ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d Yonsei University College of Medicine   (South Korea)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; LUCIFERASE; MICRORNA; MICRORNA 486; PROTEIN OLFM3; PROTEIN OLFM4; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCUS; GENE LOSS; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN TARGETING; REPORTER GENE; STOMACH CANCER; STOMACH TUMOR;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENOMIC INSTABILITY; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; NEOPLASMS; STOMACH NEOPLASMS;

EID: 79955519937     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-3152     Document Type: Article

References (50)

1. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. editors. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute; 2008. Available from: http://seer.cancer.gov/csr/1975-2005/.
2. Ang TL, Khor CJ, Gotoda T. Diagnosis and endoscopic resection of early gastric cancer. Singapore Med J 2010;51:93-100.
3. Wöhrer SS, Raderer M, Hejna M. Palliative chemotherapy for advanced gastric cancer. Ann Oncol 2004;15:1585-95. (Pubitemid 39567288)
4. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-42. (Pubitemid 30088655)
5. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-24. (Pubitemid 34327521)
6. Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell 2004;5:121-5. (Pubitemid 38283798)
7. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs- the micro steering wheel of tumour metastases. Nat Rev Cancer 2009;9:293-302.
8. Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 2006;25:6163-9. (Pubitemid 44527846)
9. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006;11:441-50. (Pubitemid 44430905)
10. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33.
11. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005;433:769-73. (Pubitemid 40292988)
12. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006;25:6188-96. (Pubitemid 44527849)
13. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 2006;124:1169-81
14. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY, et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008;18:350-9. (Pubitemid 351333899)
15. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009;37:1672-81.
16. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009;24:652-7.
17. Chan SH, Wu CW, Li AF, Chi CW, Lin WC. miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 2008;28:907-11. (Pubitemid 351578936)
18. Liu T, Tang H, Lang Y, Liu M, Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009;273:233-42.
19. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008;13:272-86. (Pubitemid 351318375)
20. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, Akao Y, et al. Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 2009;77:12-21.
21. Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T, et al. Down-regulation of miR- 141 in gastric cancer and its involvement in cell growth. J Gastroenterol 2009;44:556-61.
22. Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, deAngelis T, Baserga R, et al. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 2007; 282:32582-90 (Pubitemid 350159311)
23. Luo H, Zhang H, Zhang Z, Zhang X, Ning B, Guo J, et al. Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res 2009;28:82.
24. Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H, et al. Reduced microRNA- 218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010;116:41-49.
25. Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z. Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One 2009;4:e8003.
26. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
27. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 2010;126:1166-76.
28. Yang Z, Chen S, Luan X, Li Y, Liu M, Li X, et al. MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life 2009;61:1075-82.
29. Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 2010;70:2339-49.
30. Small EM, O'Rourke JR, Moresi V, Sutherland LB, McAnally J, Gerard RD, et al. Regulation of PI3-kinase/Akt signaling by muscle- enriched microRNA-486. Proc Natl Acad Sci U S A 2010;107:4218-23.
31. Hashimoto Y, Akiyama Y, Otsubo T, Shimada S, Yuasa Y, et al. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Carcinogenesis 2010;31:777-84.
32. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008;322:1695-9.
33. Vecchione A, Ishii H, Shiao YH, Trapasso F, Rugge M, Tamburrino JF, et al. Fez1/lzts1 alterations in gastric carcinoma. Clin Cancer Res 2001;7:1546-52. (Pubitemid 32708618)
34. Cunningham C, Dunlop MG, Wyllie AH, Bird CC. Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Oncogene 1993;8:1391-6. (Pubitemid 23129865)
35. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, et al. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 1995;55:5390-5.
36. Huang J, Zhao YL, Li Y, Fletcher JA, Xiao S. Genomic and functional evidence for an ARID1A tumor suppressor role. Genes Chromosomes Cancer 2007;46:745-50. (Pubitemid 46912345)
37. O'Malley S, Su H, Zhang T, Ng C, Ge H, Tang CK, et al. TOB suppresses breast cancer tumorigenesis. Int J Cancer 2009;125:1805-13.
38. Takahashi M, Nakamura Y, Obama K, Furukawa Y. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Int J Oncol 2005;27:1483-7.
39. Oue N, Sentani K, Noguchi T, Ohara S, Sakamoto N, Hayashi T, et al. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 2009;125:2383-92.
40. Liu W, Zhu J, Cao L, Rodgers GP. Expression of hGC-1 is correlated with differentiation of gastric carcinoma. Histopathology 2007;51:157-65. (Pubitemid 47084003)
41. Tomarev SI, Nakaya N. Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology. Mol Neurobiol 2009;40:122-38.
42. Zhang X, Huang Q, Yang Z, Li Y, Li CY. GW112, a novel antiapoptotic protein that promotes tumor growth. Cancer Res 2004;64:2474-81. (Pubitemid 38523902)
43. Kim KK, Park KS, Song SB, Kim KE. Up regulation of GW112 Gene by NF kappaB promotes an antiapoptotic property in gastric cancer cells. Mol Carcinog 2010;49:259-70.
44. Tay ST, Leong SH, Yu K, Aggarwal A, Tan SY, Lee CH, et al. A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes. Cancer Res 2003;63:3309-16. (Pubitemid 36735888)
45. Kakinuma N, Kohu K, Sato M, Yamada T, Nakajima M, Akiyama T, et al. Candidate regions of tumor suppressor gene by loss of heterozygosity analysis on chromosome 8p11.1-q13.3 in gastric cancer. Cancer Lett 2004;213:111-6. (Pubitemid 39118539)
46. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-9. (Pubitemid 35403967)
47. Wilting SM, van Boerdonk RA, Henken FE, Meijer CJ, Diosdado B, Meijer GA, et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer 2010;9:167.
48. Mott JL, Kurita S, Cazanave SC, Bronk SF, Werneburg NW, Fernandez- Zapico ME, et al. Transcriptional suppression of mir-29b-1/mir- 29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem 2010;110:1155-64.
49. Liu W, Lee HW, Liu Y, Wang R, Rodgers GP. Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2′-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis. Blood 2010;116:4938-47.
50. Van Der Flier LG, Haegebarth A, Stange DE, van de Wetering M, Clevers H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 2009;137:15-7.